ANALABS Stock Overview
An investment holding company, manufactures, formulates, and sells resins, chemicals, and building materials in Malaysia, rest of Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Analabs Resources Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 1.77 |
| 52 Week High | RM 1.92 |
| 52 Week Low | RM 1.55 |
| Beta | 0.19 |
| 1 Month Change | 12.03% |
| 3 Month Change | 1.72% |
| 1 Year Change | -1.67% |
| 3 Year Change | 22.07% |
| 5 Year Change | 60.91% |
| Change since IPO | -28.72% |
Recent News & Updates
Recent updates
Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?
Jan 04
Analabs Resources Berhad (KLSE:ANALABS) Is Due To Pay A Dividend Of MYR0.02
Feb 13Analabs Resources Berhad (KLSE:ANALABS) Is Doing The Right Things To Multiply Its Share Price
Mar 28Analabs Resources Berhad (KLSE:ANALABS) Has A Pretty Healthy Balance Sheet
Jan 21Here's Why Analabs Resources Berhad (KLSE:ANALABS) Can Manage Its Debt Responsibly
Sep 13Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?
May 24Analabs Resources Berhad (KLSE:ANALABS) Might Be Having Difficulty Using Its Capital Effectively
Apr 28Here's Why We Think Analabs Resources Berhad (KLSE:ANALABS) Is Well Worth Watching
Apr 07Could Analabs Resources Berhad (KLSE:ANALABS) Have The Makings Of Another Dividend Aristocrat?
Mar 17Should You Buy Analabs Resources Berhad (KLSE:ANALABS) For Its Upcoming Dividend?
Feb 19Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?
Feb 09
Is Analabs Resources Berhad (KLSE:ANALABS) Set To Make A Turnaround?
Jan 14Is Analabs Resources Berhad (KLSE:ANALABS) An Attractive Dividend Stock?
Dec 07Shareholder Returns
| ANALABS | MY Chemicals | MY Market | |
|---|---|---|---|
| 7D | 0% | -0.4% | -1.4% |
| 1Y | -1.7% | -38.7% | -9.2% |
Return vs Industry: ANALABS exceeded the MY Chemicals industry which returned -38.7% over the past year.
Return vs Market: ANALABS exceeded the MY Market which returned -9.2% over the past year.
Price Volatility
| ANALABS volatility | |
|---|---|
| ANALABS Average Weekly Movement | 4.7% |
| Chemicals Industry Average Movement | 6.7% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in MY Market | 12.2% |
| 10% least volatile stocks in MY Market | 3.3% |
Stable Share Price: ANALABS has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: ANALABS's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1936 | n/a | Mun Kan | www.analabs.com.my |
Analabs Resources Berhad, an investment holding company, manufactures, formulates, and sells resins, chemicals, and building materials in Malaysia, rest of Asia, and internationally. The company operates through five segments: Manufacturing, Formulation, and Sale of Resin, Chemicals, and Building Materials; Contract Work, Pipe Laying and Rehabilitation; Investment Holding and Property Letting; Recovery and Sale of Recycled Products; and Culture and Sale of Prawns. It also collects, treats, recovers, and recycles industrial and organic waste, as well as sells recycled products.
Analabs Resources Berhad Fundamentals Summary
| ANALABS fundamental statistics | |
|---|---|
| Market cap | RM 192.81m |
| Earnings (TTM) | RM 32.56m |
| Revenue (TTM) | RM 124.73m |
Is ANALABS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ANALABS income statement (TTM) | |
|---|---|
| Revenue | RM 124.73m |
| Cost of Revenue | RM 86.27m |
| Gross Profit | RM 38.46m |
| Other Expenses | RM 5.90m |
| Earnings | RM 32.56m |
Last Reported Earnings
Jan 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.30 |
| Gross Margin | 30.84% |
| Net Profit Margin | 26.11% |
| Debt/Equity Ratio | 47.6% |
How did ANALABS perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/01 18:45 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/01/31 |
| Annual Earnings | 2024/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Analabs Resources Berhad is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.